RH, M., MA, M., ES, S., EM, M., OO, A., MO, A. A., . . . DE, E. (2022). Author Correction: Assessment of the cardioprotective effect of liraglutide on methotrexate induced cardiac dysfunction through suppression of inflammation and enhancement of angiogenesis in rats. European review for medical and pharmacological sciences, 26(2), 345. https://doi.org/10.26355/eurrev_202201_27853
Chicago Style (17th ed.) CitationRH, Mahmoud, Mohammed MA, Said ES, Morsi EM, Abdelaleem OO, Abdel All MO, Elsayed RM, Abdelmeguid EA, and Eldosoki DE. "Author Correction: Assessment of the Cardioprotective Effect of Liraglutide on Methotrexate Induced Cardiac Dysfunction Through Suppression of Inflammation and Enhancement of Angiogenesis in Rats." European Review for Medical and Pharmacological Sciences 26, no. 2 (2022): 345. https://doi.org/10.26355/eurrev_202201_27853.
MLA (9th ed.) CitationRH, Mahmoud, et al. "Author Correction: Assessment of the Cardioprotective Effect of Liraglutide on Methotrexate Induced Cardiac Dysfunction Through Suppression of Inflammation and Enhancement of Angiogenesis in Rats." European Review for Medical and Pharmacological Sciences, vol. 26, no. 2, 2022, p. 345, https://doi.org/10.26355/eurrev_202201_27853.